Andere talen Rohto Pharmaceutical Co.,Ltd.

Aandelen

4527

JP3982400008

Beurs gesloten - Japan Exchange Andere beurzen 08:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3.083 ^JPY	+1,55%		+3,63%	+8,44%

04/04	Mitsui en Rohto kopen $594 mln Chinees geneesmiddelenbedrijf Eu Yan Sang	RE
2023	Japanse aandelen sluiten maandag marginaal hoger in aanloop naar ontmoeting Biden-Xi	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen	04/04
Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update	04/04
Mitsui and Rohto to buy $594 mln Chinese medicines company Eu Yan Sang	04/04
Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang	04/04
Rohto Pharmaceutical Co.,Ltd., Mitsui & Co., Ltd. and others agreed to acquire an 86% stake in Eu Yan Sang International Ltd from Blanca Investments Pte. Ltd., Tower Capital Asia and founding family for approximately SGD 690 million.	04/04
FiNC Technologies Co., Ltd. announced that it has received funding from Rohto Pharmaceutical Co.,Ltd.	28/03
Rohto Pharmaceutical's Profit Climbs 21% in Fiscal Nine Months, Lifts Fiscal-Year Outlook	12/02
Alina Vision Pte Ltd. announced that it has received funding from Fred Hollows Foundation, Rohto Pharmaceutical Co.,Ltd., TVM Capital Healthcare Partners	16/01
Plantex Co., Ltd. announced that it has received funding from Rohto Pharmaceutical Co.,Ltd., Dai-ichi Life Holdings, Inc., RealTechJapan LLC.	30/11
Rohto Pharmaceutical Co.,Ltd.(TSE:4527) added to S&P Japan Mid Cap 100	29/11
Japanese Shares Close Marginally Higher Monday Ahead of Biden-Xi Meeting	13/11
Rohto Pharmaceutical’s Attributable Profit Soars 25.8% in Fiscal H1 on Significant Profit Increases Across Categories	13/11
Rohto Pharmaceutical Co.,Ltd. Provides Dividend Guidance for the Full Year Ending March 31, 2024	10/11
Rohto Pharmaceutical Co.,Ltd. Declares Dividend for the Second Quarter of Fiscal Ending March 31, 2024, Payable on December 7, 2023	10/11
Rohto Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	10/11
Australis Scientific Pty Ltd. announced that it has received funding from Rohto Pharmaceutical Co.,Ltd.	25-10-23
Butterfly Pea Laboratory Co., Ltd. announced that it has received funding from Rohto Pharmaceutical Co.,Ltd. and other investors.	02-10-23
Rohto Pharmaceutical’s Attributable Profit Rises 30% in Fiscal Q1 due to Significant Sales Increase	25-08-23
Rohto Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	09-08-23
Rohto Pharmaceutical Co.,Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	09-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Headlines

Rohto Pharmaceutical Co. Ltd.: kampioen van het receptvrije geneesmiddel

21 maart 2023 om 19:09 uur